- Home
- XBP vs OTLK Comparison
XBP vs OTLK Comparison
Compare XBP & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBP
- OTLK
- Stock Information
- Founded
- XBP N/A
- OTLK 2010
- Country
- XBP United Kingdom
- OTLK United States
- Employees
- XBP N/A
- OTLK N/A
- Industry
- XBP Business Services
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XBP Consumer Discretionary
- OTLK Health Care
- Exchange
- XBP Nasdaq
- OTLK Nasdaq
- Market Cap
- XBP 32.0M
- OTLK 33.6M
- IPO Year
- XBP N/A
- OTLK 2016
- Fundamental
- Price
- XBP $1.09
- OTLK $2.24
- Analyst Decision
- XBP
- OTLK Strong Buy
- Analyst Count
- XBP 0
- OTLK 6
- Target Price
- XBP N/A
- OTLK $28.68
- AVG Volume (30 Days)
- XBP 197.8K
- OTLK 1.3M
- Earning Date
- XBP 11-12-2024
- OTLK 02-12-2025
- Dividend Yield
- XBP N/A
- OTLK N/A
- EPS Growth
- XBP N/A
- OTLK N/A
- EPS
- XBP N/A
- OTLK N/A
- Revenue
- XBP $157,146,000.00
- OTLK N/A
- Revenue This Year
- XBP N/A
- OTLK N/A
- Revenue Next Year
- XBP N/A
- OTLK $959.82
- P/E Ratio
- XBP N/A
- OTLK N/A
- Revenue Growth
- XBP N/A
- OTLK N/A
- 52 Week Low
- XBP $0.79
- OTLK $0.87
- 52 Week High
- XBP $5.55
- OTLK $12.85
- Technical
- Relative Strength Index (RSI)
- XBP 48.86
- OTLK 48.03
- Support Level
- XBP $0.98
- OTLK $1.26
- Resistance Level
- XBP $1.22
- OTLK $2.18
- Average True Range (ATR)
- XBP 0.21
- OTLK 0.22
- MACD
- XBP 0.00
- OTLK 0.23
- Stochastic Oscillator
- XBP 27.52
- OTLK 91.59
About XBP XBP Europe Holdings Inc.
XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.